- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01147913
Computerized Information-Processing Bias Retraining in Depressed Adolescents
May 2, 2012 updated by: Jamie A. Micco, PhD, Massachusetts General Hospital
Computerized Information-Processing Bias Retraining in Adolescents With Depression: A Controlled Trial
This study will examine how well a novel four-session computerized program, designed to help adolescents learn to interpret ambiguous situations less negatively, reduces symptoms of depression and decreases negative information-processing biases.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Major Depression is a markedly impairing disorder that affects up to 20% of adolescents before adulthood, and is associated with significant impairment in adolescents' emotional and social development.
While antidepressant medication and psychotherapy are effective in treating some depressed adolescents, approximately 30% fail to respond to a combination of these treatments.
Furthermore, many families are reluctant to pursue antidepressant medication for depressed adolescents because of concerns about potentially increasing risk of suicidal ideation.
Thus, there is a critical need for effective, non-pharmacological treatments for this population.
One promising new intervention consists of modifying negative information-processing biases associated with depression.
Recent research has suggested that these biases may be modified using a computerized program that provides repeated exposure to positive interpretations of salient, ambiguous situations, with the goal of interpreting ambiguity less negatively.
These modification programs have been efficacious in altering interpretation biases and reducing anxiety in adults with social and specific phobias.
Therefore, the proposed study aims to examine the efficacy of an adapted interpretation bias modification program for depressed adolescents.
Specifically, the study will examine the efficacy of four sessions of the modification program in altering interpretation biases and reducing symptoms of depression, anxiety, and negative affect.
A total of 60 adolescents (ages 14-21) with symptoms of major depression will be randomly assigned to either the active intervention condition (four sessions of the modification program over two weeks) or an attention control condition.
Measures will include a diagnostic interview, self-report measures of depression, anxiety, and negative affect, and a test of interpretation bias in response to ambiguous situations.
It is hypothesized that: 1) Compared to adolescents in the attention control condition, adolescents who receive four sessions of the positive interpretive training will experience a significantly larger decrease from baseline to post-treatment in negative interpretation bias (e.g., more positive and fewer negative interpretations of ambiguous situations) on a measure of interpretation bias; and, 2)Compared to adolescents in the attention control condition, adolescents who receive the positive interpretation training will experience a significantly larger decrease from baseline to post-treatment in self-reported state depression, anxiety, and negative affect.
Study Type
Interventional
Enrollment (Actual)
48
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Massachusetts
-
Cambridge, Massachusetts, United States, 02138
- Clinical and Research Program in Pediatric Psychopharmacology at Massachusetts General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 21 years (ADULT, CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Participants must be between 14-21 years old
- A score of 14 or higher on the Beck Depression Inventory, 2nd Edition (BDI-II)
- Working command of the English language
Exclusion Criteria:
- Psychosis, current mania, or acute suicidality
- Previous diagnosis of pervasive developmental disorder, mental retardation, or severe dyslexia
- Changes in psychiatric medication or psychotherapy within two weeks of entering the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Positive Interpretation Training
Four sessions of positive information-processing training for interpretation of ambiguous scenarios relevant to themes of depression.
|
The intervention consists of the presentation of three-line ambiguous scenarios via a computer program, one line at a time.
A disambiguating word fragment completes the scenario (in either a positive or neutral valence, depending on the scenario), after which participants will type the first letter of the word on the keyboard to ensure they are encoding the interpretation valence.
The computer will indicate if they have correctly identified the word.
This is followed by a Y/N comprehension question.
Each session presents 100 training scenarios.
|
|
SHAM_COMPARATOR: Attention Control Training
Four sessions of interpretation training for "filler" or neutral scenarios, unrelated to themes associated with depression.
|
Four sessions of interpretation training for "filler" or neutral scenarios, unrelated to themes associated with depression.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Test of Interpretation Bias (TIB)
Time Frame: up to 1 day post-treatment
|
The TIB consists of 10 scenarios, similar to the training scenarios except that the last word of all of the scenarios remains ambiguous in valence.
Following exposure to each of these ambiguous scenarios, adolescents are given a series of four statements regarding the scenario and asked to rate on a 4-point scale how similar the statement is to their interpretation of the scenario.
Two target statements are presented, one with the positive interpretation and one with the negative interpretation.
Scores for negative and positive interpretations across the situations can then be calculated.
|
up to 1 day post-treatment
|
|
Test of Interpretation Bias
Time Frame: 2-Week Follow-Up
|
See above
|
2-Week Follow-Up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Kiddie-Schedule of Affective Disorders and Schizophrenia-Epidemiologic Version (K-SADS-E; Orvaschek & Puig-Antich, 1987)
Time Frame: up to one day Post-Treatment and at 2-Week Follow-Up
|
DSM-IV structured interview for children up to age 16 years old; assesses for major depression, dysthymia, and mania.
|
up to one day Post-Treatment and at 2-Week Follow-Up
|
|
Beck Depression Inventory, 2nd Version
Time Frame: up to 1 day Post-Treatment and at 2-Week Follow-Up
|
The BDI-II is a questionnaire the measures symptoms of depression over the previous two weeks.
|
up to 1 day Post-Treatment and at 2-Week Follow-Up
|
|
State-Trait Anxiety Scale (STAI)
Time Frame: up to 1 day Post-Treatment and 2-Week Follow-Up
|
The STAI is a self-report measure of anxiety symptoms over the past week (trait) and currently (state).
|
up to 1 day Post-Treatment and 2-Week Follow-Up
|
|
Structured Clinical Interview for DSM-IV (SCID-IV; First et al, 1997), Mood Disorder Modules only
Time Frame: up to 1 day Post-Treatment and 2-Week Follow-Up
|
DSM-IV structured interview for adults (17 years old and older); assesses for major depression, dysthymia, and mania
|
up to 1 day Post-Treatment and 2-Week Follow-Up
|
|
Dysfunctional Attitudes Scale (DAS)
Time Frame: up to 1 day post-treatment and at two-week follow-up
|
The DAS-A is a 40-item self-report measure of depressogenic beliefs.
The scale has two factors: Perfectionism and Need for Social Approval (Imber et al., 1990).
Internal consistency and concurrent validity have been found to be acceptable (Imber et al, 1990; Blatt et al, 1995).
|
up to 1 day post-treatment and at two-week follow-up
|
|
CANTAB Affective Go-No Go Task (AGN)
Time Frame: up to 1 day post-treatment
|
The AGN test assesses information processing biases for positive and negative stimuli and takes 10 minutes to administer.
The test consists of several blocks, each of which presents a series of words from two of three different Affective categories: Positive (for example, joyful), Negative (for example, hopeless), and Neutral (for example, element).
The subject is given a target category, and is asked to press the press pad when they see a word matching this category.
There are twelve outcome measures covering latency and errors of commission and omission.
|
up to 1 day post-treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jamie A Micco, PhD, Massachusetts General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2010
Primary Completion (ACTUAL)
April 1, 2012
Study Completion (ACTUAL)
April 1, 2012
Study Registration Dates
First Submitted
April 12, 2010
First Submitted That Met QC Criteria
June 18, 2010
First Posted (ESTIMATE)
June 22, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
May 3, 2012
Last Update Submitted That Met QC Criteria
May 2, 2012
Last Verified
May 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- F32MH088065-01
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.